Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanny Duval

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Neurology|February 6, 2022
Neurologic manifestations of giant cell arteritisAntoine Soulages, Igor Sibon, Jean-Michel Vallat, et al.
European Journal of Neurology|March 18, 2022
Macroglossia: A potentially severe complication of late-onset Pompe diseaseCharlotte Dupé, Claire Lefeuvre, Guilhem Solé, et al.
Journal of Neurology|December 5, 2023
Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)Madeleine Hazard, Fanny Duval, Caroline Dutriaux, et al.
European Journal of Human Genetics : EJHG|April 19, 2019
LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2Alessia Peretti, Maud Perie, Didier Vincent, et al.
Journal of Neurology|March 22, 2024
Phenotype variability and natural history of X-linked myopathy with excessive autophagyGorka Fernández-Eulate, Girolamo Alfieri, Marco Spinazzi, et al.
Journal of Neurology|February 15, 2022
Peripheral neuropathy and livedoid vasculopathyAntoine Soulages, Thierry Maisonobe, Pascal Auzou, et al.
Frontiers in Oncology|July 23, 2024
Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysisCéline Eldani, Marie Kostine, Maxime Faure, et al.
Neurology|February 11, 2021
Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia GravisGuilhem Solé, Stéphane Mathis, Diane Friedman, et al.
Journal of Neuromuscular Diseases|March 29, 2026
Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in FranceGiulia Tammam, Abderhmane Slioui, Diane Friedman, et al.
Journal for Immunotherapy of Cancer|December 5, 2019
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive studyGuillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Neurology|February 6, 2022
Neurologic manifestations of giant cell arteritisAntoine Soulages, Igor Sibon, Jean-Michel Vallat, et al.
European Journal of Neurology|March 18, 2022
Macroglossia: A potentially severe complication of late-onset Pompe diseaseCharlotte Dupé, Claire Lefeuvre, Guilhem Solé, et al.
Journal of Neurology|December 5, 2023
Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)Madeleine Hazard, Fanny Duval, Caroline Dutriaux, et al.
European Journal of Human Genetics : EJHG|April 19, 2019
LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2Alessia Peretti, Maud Perie, Didier Vincent, et al.
Journal of Neurology|March 22, 2024
Phenotype variability and natural history of X-linked myopathy with excessive autophagyGorka Fernández-Eulate, Girolamo Alfieri, Marco Spinazzi, et al.
Journal of Neurology|February 15, 2022
Peripheral neuropathy and livedoid vasculopathyAntoine Soulages, Thierry Maisonobe, Pascal Auzou, et al.
Frontiers in Oncology|July 23, 2024
Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysisCéline Eldani, Marie Kostine, Maxime Faure, et al.
Neurology|February 11, 2021
Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia GravisGuilhem Solé, Stéphane Mathis, Diane Friedman, et al.
Journal of Neuromuscular Diseases|March 29, 2026
Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in FranceGiulia Tammam, Abderhmane Slioui, Diane Friedman, et al.
Journal for Immunotherapy of Cancer|December 5, 2019
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive studyGuillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, et al.
Pageof 5